References
- Arbyn M, Castellsagué X, de Sanjosé S, Bruni L, Saraiya M, Bray F, et al. Worldwide burden of cervical cancer in 2008. Ann Oncol 2011; 22: 2675–2686
- http://seer.cancer.gov/statfacts/html/cervix.html#survival
- Rose PG, Bundy BN, Watkins J, et al. Concurrent cisplatin-based chemotherapy and radiotherapy for locally advanced cervical cancer. N Engl J Med 1999; 340: 1144–1153
- Peters WA, III, Liu PY, Barrett R, et al. Concurrent chemotherapy and pelvic radiation therapy compared with pelvic radiation therapy alone as adjuvant therapy after radical surgery in high-risk early-stage cancer of the cervix. J Clin Oncol 2000; 18: 1606–1613
- Morris M, Eifel PJ, Lu J, et al. Pelvic radiation with concurrent chemotherapy compared with pelvic and para-aortic radiation for high-risk cervical cancer. N Engl J Med 1999; 340: 1137–1143
- Keys HM, Bundy BN, Stehman FB, et al. Cisplatin, radiation, and adjuvant hysterectomy for bulky stage IB cervical carcinoma. N Engl J Med 1999; 340: 1154–1161
- Whitney CW, Sause W, Bundy BN, et al. Randomised comparison of fluorouracil plus cisplatin versus hydroxyurea as an adjunct to radiation therapy in stage IIB–IVA carcinoma of the cervix with negative para-aortic lymph nodes: A Gynecologic Oncology Group and Southwest Oncology Group study. J Clin Oncol 1999; 17: 1339–1348
- National Cancer Institute. Concurrent chemoradiation for cervical cancer. Clinical announcement, Washington, DC, February 22, 1999.
- Overgaard J. Fractionated radiation and hyperthermia. Experimental and clinical studies. Cancer 1981; 48: 1116–1123
- Van der Zee J, González González D, Rhoon GC van, et al. Comparison of radiotherapy alone with radiotherapy plus hyperthermia in locally advanced pelvic tumours: A prospective, randomised, multicentre trial. Lancet 2000; 355: 1119–1125
- Harima Y, Nagata K, Harima K, et al. A randomised clinical trial of radiation therapy versus thermoradiotherapy in stage IIIB cervical carcinoma. Int J Hyperthermia 2001; 17: 97–105
- Harima Y, Sawada S. Hyperthermia classic commentary: ‘A randomized clinical trial of radiation therapy versus thermoradiotherapy in stage IIIB cervical carcinoma’ by Yoko Harima. Int J Hyperthermia 2001; 17: 97–105, Int J Hyperthermia 2009;25:344–346
- Urano M, Kahn J, Majima H, et al. The cytotoxic effect of CDDP on cultured CHO cells at elevated temperature: Arrhenius plot analysis. Int J Hyperthermia 1990; 6: 581–590
- Rietbroek RC, Schilthuis MS, Bakker PJM, et al. Phase II trial of weekly locoregional hyperthermia and cisplatin in patients with previously irradiated recurrent carcinoma of the uterine cervix. Cancer 1997; 79: 935–943
- de Wit R, van der Zee J, van der Burg ME, et al. A phase I/II study of combined weekly systemic cisplatin and locoregional hyperthermia in patients with previously irradiated recurrent carcinoma of the uterine cervix. Br J Cancer 1999; 80: 1387–1391
- Franckena M, De Wit R, Ansink AC, Notenboom A, Canters RA M, Fatehi D, et al. Weekly systemic cisplatin plus locoregional hyperthermia: An effective treatment for patients with recurrent cervical carcinoma in a previously irradiated area. Int J Hyperthermia 2007; 23: 443–450
- Herman TS, Teicher BA. Sequencing of trimodality therapy [cis-diamminedichloroplatinum(II)/hyperthermia/radiation] as determined by tumor growth delay and tumor cell survival in the FSaIIC fibrosarcoma. Cancer Res 1988; 48: 2693–2697
- Herman TS, Jochelson MS, Teicher BA, et al. A phase I/II trial of cisplatin, hyperthermia and radiation in patients with locally advanced malignancies. Int J Radiat Oncol Biol Phys 1989; 17: 1273–1279
- Westermann AM, Jones EL, Schem BC, et al. First results of triple modality treatment by combining radiotherapy, chemotherapy and hyperthermia for the treatment of stage IIB–III–IVA cervical cancer. Cancer 2005; 104: 763–770
- Monk BJ, Tian C, Rose PG, et al. Which clinical/pathologic factors matter in the era of chemoradiation as treatment for locally advanced cervical carcinoma? Analysis of two Gynecologic Oncology Group (GOG) trials. Gynecol Oncol 2007; 105: 427–433
- www.kankerregistratie.nl